Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 201

1.

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.

Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P.

Alzheimers Res Ther. 2019 Apr 22;11(1):34. doi: 10.1186/s13195-019-0485-0. Review.

2.

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.

Senel M, Mojib-Yezdani F, Braisch U, Bachhuber F, Lewerenz J, Ludolph AC, Otto M, Tumani H.

Front Immunol. 2019 Mar 29;10:641. doi: 10.3389/fimmu.2019.00641. eCollection 2019.

3.

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

Abdelhak A, Hottenrott T, Morenas-Rodríguez E, Suárez-Calvet M, Zettl UK, Haass C, Meuth SG, Rauer S, Otto M, Tumani H, Huss A.

Front Neurol. 2019 Mar 26;10:280. doi: 10.3389/fneur.2019.00280. eCollection 2019.

4.

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.

Al Shweiki MR, Steinacker P, Oeckl P, Hengerer B, Danek A, Fassbender K, Diehl-Schmid J, Jahn H, Anderl-Straub S, Ludolph AC, Schönfeldt-Lecuona C, Otto M.

J Psychiatr Res. 2019 Jun;113:137-140. doi: 10.1016/j.jpsychires.2019.03.019. Epub 2019 Mar 24.

PMID:
30953863
5.

Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging.

Albrecht F, Mueller K, Ballarini T, Lampe L, Diehl-Schmid J, Fassbender K, Fliessbach K, Jahn H, Jech R, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Ludolph AC, Lyros E, Prudlo J, Schneider A, Synofzik M, Wiltfang J, Danek A, Otto M; FTLD-Consortium, Schroeter ML.

Cortex. 2019 Feb 25;117:33-40. doi: 10.1016/j.cortex.2019.02.015. [Epub ahead of print]

6.

A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.

Devos D, Moreau C, Kyheng M, Garçon G, Rolland AS, Blasco H, Gelé P, Timothée Lenglet T, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meninger V, Danel-Brunaud V, Devedjian JC, Duce JA, Pradat PF.

Sci Rep. 2019 Feb 27;9(1):2918. doi: 10.1038/s41598-019-39739-5.

7.

Serum NFL discriminates Parkinson disease from atypical parkinsonisms.

Marques TM, van Rumund A, Oeckl P, Kuiperij HB, Esselink RAJ, Bloem BR, Otto M, Verbeek MM.

Neurology. 2019 Mar 26;92(13):e1479-e1486. doi: 10.1212/WNL.0000000000007179. Epub 2019 Feb 27.

PMID:
30814322
8.

The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint.

Premi E, Calhoun VD, Diano M, Gazzina S, Cosseddu M, Alberici A, Archetti S, Paternicò D, Gasparotti R, van Swieten J, Galimberti D, Sanchez-Valle R, Laforce R Jr, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia MC, Rowe J, Vandenberghe R, Finger E, Tagliavini F, de Mendonça A, Santana I, Butler C, Ducharme S, Gerhard A, Danek A, Levin J, Otto M, Frisoni G, Cappa S, Sorbi S, Padovani A, Rohrer JD, Borroni B; Genetic FTD Initiative, GENFI.

Neuroimage. 2019 Apr 1;189:645-654. doi: 10.1016/j.neuroimage.2019.01.080. Epub 2019 Feb 1.

PMID:
30716457
9.

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.

Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A, Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M; FTLDc Study Group, Grimmer T.

Transl Psychiatry. 2019 Jan 31;9(1):54. doi: 10.1038/s41398-019-0381-1.

10.

Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen.

Winter B, Guenther R, Ludolph AC, Hermann A, Otto M, Wurster CD.

J Neurol Neurosurg Psychiatry. 2019 Jan 10. pii: jnnp-2018-320033. doi: 10.1136/jnnp-2018-320033. [Epub ahead of print] No abstract available.

PMID:
30630960
11.

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.

Oeckl P, Halbgebauer S, Anderl-Straub S, Steinacker P, Huss AM, Neugebauer H, von Arnim CAF, Diehl-Schmid J, Grimmer T, Kornhuber J, Lewczuk P, Danek A; Consortium for Frontotemporal Lobar Degeneration German, Ludolph AC, Otto M.

J Alzheimers Dis. 2019;67(2):481-488. doi: 10.3233/JAD-180325.

PMID:
30594925
12.

On Razor's edge: Managing analgosedation during severe anti-NMDA receptor encephalitis.

Jesse S, Wagner J, Gastl R, Steinacker P, Otto M, Kassubek J, Lewerenz J.

Neurol Neuroimmunol Neuroinflamm. 2018 Nov 19;6(1):e522. doi: 10.1212/NXI.0000000000000522. eCollection 2019 Jan. No abstract available.

13.

The applause sign in frontotemporal lobar degeneration and related conditions.

Schönecker S, Hell F, Bötzel K, Wlasich E, Ackl N, Süßmair C; German FTLD Consortium, Otto M, Anderl-Straub S, Ludolph A, Kassubek J, Huppertz HJ, Diehl-Schmid J, Riedl L, Roßmeier C, Fassbender K, Lyros E, Kornhuber J, Oberstein TJ, Fliessbach K, Schneider A, Schroeter ML, Prudlo J, Lauer M, Jahn H, Levin J, Danek A.

J Neurol. 2019 Feb;266(2):330-338. doi: 10.1007/s00415-018-9134-y. Epub 2018 Dec 1.

PMID:
30506397
14.

Moral judgment in patients with behavioral variant of frontotemporal dementia and amyotrophic lateral sclerosis: no impairment of the moral position, but rather its execution.

Semler E, Petersdorff L, Anderl-Straub S, Böhm S, Lulé D, Fangerau H, Ludolph AC, Otto M, Uttner I.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):12-18. doi: 10.1080/21678421.2018.1534972. Epub 2018 Dec 4.

PMID:
30513214
15.

"Microchip Electrophoresis," with Respect to "Profiling of Aβ Peptides in the Cerebrospinal Fluid of Patients with Alzheimer's Disease".

Mohamadi MR, Verpillot R, Taverna M, Otto M, Viovy JL.

Methods Mol Biol. 2019;1855:327-340. doi: 10.1007/978-1-4939-8793-1_28.

PMID:
30426429
16.

Biomarkers for diseases with TDP-43 pathology.

Steinacker P, Barschke P, Otto M.

Mol Cell Neurosci. 2018 Nov 3. pii: S1044-7431(18)30310-5. doi: 10.1016/j.mcn.2018.10.003. [Epub ahead of print] Review.

PMID:
30399416
17.

Analysis of CACNA1A CAG repeat lengths in patients with familial ALS.

Brenner D, Müller K, Gastl R, Gorges M, Otto M, Pinkhardt EH, Kassubek J, Weishaupt JH, Ludolph AC.

Neurobiol Aging. 2019 Feb;74:235.e5-235.e8. doi: 10.1016/j.neurobiolaging.2018.09.019. Epub 2018 Sep 22.

PMID:
30342765
18.

Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.

Hüttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S, Wiltfang J, Wirths O.

Acta Neuropathol Commun. 2018 Oct 19;6(1):108. doi: 10.1186/s40478-018-0612-3.

19.

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.

Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, Tumani H, von Arnim CAF, Dorst J, Feneberg E, Mayer B, Müller HP, Gorges M, Rosenbohm A, Volk AE, Silani V, Ludolph AC, Otto M.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):157-164. doi: 10.1136/jnnp-2018-318704. Epub 2018 Oct 11.

PMID:
30309882
20.

Story of the ALS-FTD continuum retold: rather two distinct entities.

Lulé DE, Aho-Özhan HEA, Vázquez C, Weiland U, Weishaupt JH, Otto M, Anderl-Straub S, Semler E, Uttner I, Ludolph AC.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):586-589. doi: 10.1136/jnnp-2018-318800. Epub 2018 Sep 26.

PMID:
30257969

Supplemental Content

Loading ...
Support Center